Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study ; volume:8 ; number:1 ; day:12 ; month:9 ; year:2018 ; pages:1-10 ; date:12.2018
Scientific reports ; 8, Heft 1 (12.9.2018), 1-10, 12.2018
- Urheber
-
Liu, Chen-Hua
- Beteiligte Personen und Organisationen
-
Huang, Yi-Jie
Yang, Sien-Sing
Chang, Chung-Hsin
Yang, Sheng-Shun
Sun, Hsin-Yun
Liu, Chun-Jen
Liu, Wen-Chun
Su, Tung-Hung
Yang, Hung-Chih
Hong, Chun-Ming
Tseng, Tai-Chung
Chen, Pei-Jer
Chen, Ding-Shinn
Hung, Chien-Ching
Kao, Jia-Horng
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-32060-7
- URN
-
urn:nbn:de:101:1-2018102520464836982301
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:29 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Liu, Chen-Hua
- Huang, Yi-Jie
- Yang, Sien-Sing
- Chang, Chung-Hsin
- Yang, Sheng-Shun
- Sun, Hsin-Yun
- Liu, Chun-Jen
- Liu, Wen-Chun
- Su, Tung-Hung
- Yang, Hung-Chih
- Hong, Chun-Ming
- Tseng, Tai-Chung
- Chen, Pei-Jer
- Chen, Ding-Shinn
- Hung, Chien-Ching
- Kao, Jia-Horng
- SpringerLink (Online service)
Ähnliche Objekte (12)
Changes in tryptophan and phenylalanine in chronic HCV patients treated with direct acting antiviral (sofosbuvir)
Viral recognition and the antiviral interferon response
Interferon-free antiviral combination therapies without nucleosidic polymerase inhibitors
Interferon‐inducible phospholipids govern IFITM3 ‐dependent endosomal antiviral immunity
A systematic review of sofosbuvir/velpatasvir/voxilaprevir in HCV patients previously treated with direct-acting antivirals
Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use
Knowledge-based repositioning of the anti-HCV direct antiviral agent Sofosbuvir as SARS-CoV-2 treatment
Generic sofosbuvir and daclatasvir for treatment of hepatitis C virus infection in patients with sickle cell disease
Interferon-Stimulated Genes as Enhancers of Antiviral Innate Immune Signaling
Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era
Direct-acting antiviral resistance of Hepatitis C virus is promoted by epistasis
Interferon-lambda : a cytokine controlling innate and adaptive antiviral mucosal immunity
Changes in tryptophan and phenylalanine in chronic HCV patients treated with direct acting antiviral (sofosbuvir)
Viral recognition and the antiviral interferon response
Interferon-free antiviral combination therapies without nucleosidic polymerase inhibitors
Interferon‐inducible phospholipids govern IFITM3 ‐dependent endosomal antiviral immunity
A systematic review of sofosbuvir/velpatasvir/voxilaprevir in HCV patients previously treated with direct-acting antivirals
Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use
Knowledge-based repositioning of the anti-HCV direct antiviral agent Sofosbuvir as SARS-CoV-2 treatment
Generic sofosbuvir and daclatasvir for treatment of hepatitis C virus infection in patients with sickle cell disease
Interferon-Stimulated Genes as Enhancers of Antiviral Innate Immune Signaling
Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era
Direct-acting antiviral resistance of Hepatitis C virus is promoted by epistasis
Interferon-lambda : a cytokine controlling innate and adaptive antiviral mucosal immunity
Changes in tryptophan and phenylalanine in chronic HCV patients treated with direct acting antiviral (sofosbuvir)
Viral recognition and the antiviral interferon response
Interferon-free antiviral combination therapies without nucleosidic polymerase inhibitors
Interferon‐inducible phospholipids govern IFITM3 ‐dependent endosomal antiviral immunity
A systematic review of sofosbuvir/velpatasvir/voxilaprevir in HCV patients previously treated with direct-acting antivirals
Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use
Knowledge-based repositioning of the anti-HCV direct antiviral agent Sofosbuvir as SARS-CoV-2 treatment
Generic sofosbuvir and daclatasvir for treatment of hepatitis C virus infection in patients with sickle cell disease
Interferon-Stimulated Genes as Enhancers of Antiviral Innate Immune Signaling
Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era
Direct-acting antiviral resistance of Hepatitis C virus is promoted by epistasis